» Authors » Wenxi Tang

Wenxi Tang

Explore the profile of Wenxi Tang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 987
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wei B, Mao X, Liu S, Liu M, Wang Z, Kang P, et al.
J Environ Manage . 2024 Apr; 358:120921. PMID: 38652992
Ecological vulnerability and poverty are interrelated and must be addressed together. The resolution of this issue will help us to meet the challenges during the process of implementing concrete actions...
12.
Li X, Li Q, Duan Y, Sun H, Chu H, Jia S, et al.
PLoS One . 2024 Mar; 19(3):e0295019. PMID: 38530822
To determine whether different aspects lead to a heterogeneous distribution of soil fungi, we investigated artificially established alpine grasslands in the Muli mining area in the Qinghai-Tibet Plateau. Employing high-throughput...
13.
Li J, Miao M, Wei P, Tang W
Asian J Surg . 2024 Mar; 47(7):3250-3251. PMID: 38522983
No abstract available.
14.
Tang W, Liu H, Zhang Z, Lyu W, Wei P, Zhou H, et al.
Eur J Anaesthesiol . 2024 Feb; 41(6):421-429. PMID: 38420866
Background: Spinal anaesthesia is now the most common technique for caesarean delivery. However, because of the intermittent nature of noninvasive blood pressure (NIBP) measurements, maternal blood pressure may become hypotensive...
15.
Jiang Y, Zhao M, Tang W, Zheng X
BMC Cancer . 2024 Feb; 24(1):188. PMID: 38336718
Objective: There is limited evidence of comparative results among different treatments regarding impacts of Health-Related Quality of Life (HRQoL) for patients with metastatic colorectal cancer (mCRC). We aimed to compare...
16.
Zhao M, Shao T, Shao H, Zhou C, Tang W
BMC Cancer . 2024 Feb; 24(1):186. PMID: 38331773
Objectives: To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC). Methods: The included...
17.
Tu Y, Tang X, Zhou D, Shao H, Liang L, Tang W
Cost Eff Resour Alloc . 2024 Feb; 22(1):11. PMID: 38321475
Introduction: The treatment of hepatitis C has entered the pan-genotypic era, but the effectiveness is not good for the genotype 3b patients who have a large proportion in China. The...
18.
Shao H, Zhao M, Guan A, Shao T, Zhou D, Yu G, et al.
BMC Med . 2024 Jan; 22(1):13. PMID: 38212842
Background: Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR + /HER2 -) advanced breast cancer is a prevalent subtype among postmenopausal women. Despite the growing number of randomized clinical trials...
19.
Yin Y, Peng Q, Ma L, Dong Y, Sun Y, Xu S, et al.
Qual Life Res . 2023 Dec; 33(3):753-765. PMID: 38079024
Purpose: Quality-adjusted life-year (QALY) is a dominant measurement of health gain in economic evaluations for pricing drugs. However, end-of-life (EoL) patients' preference for QALY gains in life expectancy (LE) and...
20.
Dai W, Wu X, Li J, Tang W, Wang Y, Xu W, et al.
J Exp Clin Cancer Res . 2023 Dec; 42(1):329. PMID: 38041128
Background: Hedgehog-Gli1 signaling induces development of two common neurological features seen in pancreatic ductal adenocarcinoma (PDAC): peripheral neural invasion (PNI) and peripheral neural remodeling (PNR). However, the underlying molecular mechanisms...